John Pappajohn is Director of Vyant Bio, Inc.. Currently has a direct ownership of 4.78 Million shares of VYNT, which is worth approximately $0. The most recent transaction as insider was on Jan 31, 2019, when has been sold 1,000,000 shares (Common Stock, par value $0.0001 per share) at a price of $0.23 per share, resulting in proceeds of $230,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.78M
0% 3M change
0% 12M change
Total Value Held $0

JOHN PAPPAJOHN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2019
BUY
Open market or private purchase
$230,000 $0.23 p/Share
1,000,000 Added 17.3%
4,781,204 Common Stock, par valu...
Jan 14 2019
BUY
Open market or private purchase
$220,000 $0.22 p/Share
1,000,000 Added 20.92%
3,781,204 Common Stock, par valu...
Dec 08 2017
BUY
Open market or private purchase
$279,000 $1.86 p/Share
150,000 Added 5.12%
2,781,204 Common Stock, par valu...
Sep 28 2017
BUY
Grant, award, or other acquisition
-
2,500 Added 0.09%
2,631,204 Common Stock, par valu...
Aug 17 2017
BUY
Open market or private purchase
$280,963 $3.26 p/Share
86,185 Added 3.17%
2,628,704 Common Stock, par valu...
Jun 12 2017
BUY
Open market or private purchase
$375,000 $3.75 p/Share
100,000 Added 3.78%
2,542,519 Common Stock, par valu...
Jun 07 2017
BUY
Grant, award, or other acquisition
-
2,500 Added 0.1%
2,442,519 Common Stock, par valu...
May 16 2017
BUY
Open market or private purchase
$73,378 $3.8 p/Share
19,310 Added 0.79%
2,440,019 Common Stock, par valu...
Nov 28 2016
BUY
Open market or private purchase
$145,000 $1.45 p/Share
100,000 Added 3.97%
2,420,709 Common Stock, par valu...
Nov 14 2016
BUY
Open market or private purchase
$46,028 $1.48 p/Share
31,100 Added 1.32%
2,320,709 Common Stock, par valu...
Oct 11 2016
BUY
Grant, award, or other acquisition
-
2,500 Added 0.11%
2,289,609 Common Stock, par valu...
Aug 16 2016
BUY
Open market or private purchase
$103,050 $2.29 p/Share
45,000 Added 1.93%
2,287,109 Common Stock, par valu...
Aug 15 2016
BUY
Open market or private purchase
$175,388 $2.2 p/Share
79,722 Added 3.43%
2,242,109 Common Stock, par valu...
Aug 12 2016
BUY
Open market or private purchase
$142,334 $2.1 p/Share
67,778 Added 3.04%
2,162,387 Common Stock, par valu...
May 25 2016
BUY
Open market or private purchase
-
317,820 Added 13.15%
2,099,609 Common Stock, par valu...
Mar 17 2016
BUY
Open market or private purchase
$132,000 $2.64 p/Share
50,000 Added 2.74%
1,771,789 Common Stock, par valu...
Mar 16 2016
BUY
Open market or private purchase
$27,717 $2.62 p/Share
10,579 Added 0.61%
1,721,789 Common Stock, par valu...
Mar 15 2016
BUY
Open market or private purchase
$225,341 $2.52 p/Share
89,421 Added 4.97%
1,711,210 Common Stock, par valu...
Nov 12 2015
BUY
Open market or private purchase
-
100,000 Added 5.81%
1,621,789 Common Stock, par valu...
Oct 14 2015
BUY
Grant, award, or other acquisition
-
2,500 Added 0.16%
1,521,789 Common Stock, par valu...
Aug 27 2015
BUY
Open market or private purchase
$25,625 $10.25 p/Share
2,500 Added 0.16%
1,519,289 Common Stock, par valu...
Aug 26 2015
BUY
Open market or private purchase
$22,425 $8.97 p/Share
2,500 Added 0.16%
1,516,789 Common Stock, par valu...
May 14 2015
BUY
Open market or private purchase
$53,700 $10.74 p/Share
5,000 Added 0.33%
1,519,289 Common Stock, par valu...
Mar 17 2015
BUY
Open market or private purchase
$107,250 $7.15 p/Share
15,000 Added 0.98%
1,514,289 Common Stock, par valu...
Mar 16 2015
BUY
Open market or private purchase
$260,750 $7.45 p/Share
35,000 Added 2.28%
1,499,289 Common Stock, par valu...
JP

John Pappajohn

Director
Rutherford, NJ

Track Institutional and Insider Activities on VYNT

Follow Vyant Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYNT shares.

Notify only if

Insider Trading

Get notified when an Vyant Bio, Inc. insider buys or sells VYNT shares.

Notify only if

News

Receive news related to Vyant Bio, Inc.

Track Activities on VYNT